LAMIVUDINE AND ZIDOVUDINE

ANDA

LAMIVUDINE; ZIDOVUDINE | A079079 | PHARMOBEDIENT CONSULTING LLC

1 strength0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 9, 2008	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 150MG;300MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 12, 2019

No patent or exclusivity listings for this strength.